Symbol="PLRX"
AssetType="Common Stock"
Name="Pliant TherapeuticsÂ Inc"
Description="Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and markets new therapies for the treatment of fibrosis and related diseases in the United States. The company is headquartered in South San Francisco, California."
CIK="1746473"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="260 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1055350000"
EBITDA="-139264000"
PERatio="None"
PEGRatio="None"
BookValue="9.53"
DividendPerShare="0"
DividendYield="0"
EPS="-2.81"
RevenuePerShareTTM="0.208"
ProfitMargin="0"
OperatingMarginTTM="-14.44"
ReturnOnAssetsTTM="-0.222"
ReturnOnEquityTTM="-0.361"
RevenueTTM="9768000"
GrossProfitTTM="9685000"
DilutedEPSTTM="-2.81"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.066"
AnalystTargetPrice="46.85"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="97.43"
PriceToBookRatio="2.775"
EVToRevenue="60.87"
EVToEBITDA="-5.25"
Beta="1.259"
num_52WeekHigh="36.64"
num_52WeekLow="16.42"
num_50DayMovingAverage="20.17"
num_200DayMovingAverage="23.77"
SharesOutstanding="59156000"
DividendDate="None"
ExDividendDate="None"
symbol="PLRX"
open="17.14"
high="17.87"
low="17.14"
price="17.84"
volume="838378.00"
latest_trading_day="2023-07-31"
previous_close="17.13"
change="0.71"
change_percent="4.1448%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="71"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="29"
Volume_recent_avg="797342"
Change_recent_avg="-0.09"
Delta_recent_avg="1.15"
Variance_recent_avg="0.58"
Change_ratio_recent_avg="-0.45"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="29"
Aroon_momentum_negative="71"
image_negative_thumbnail_id_1="152"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0024.jpeg"
image_negative_thumbnail_id_2="144"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0032.jpeg"
image_neutral_thumbnail_id_1="593"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0006.jpeg"
image_neutral_thumbnail_id_2="523"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_positive_thumbnail_id_1="988"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0150.jpeg"
image_positive_thumbnail_id_2="642"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0066.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
